TuisOCEA • NASDAQ
add
Ocean Biomedical Inc
Vorige sluiting
$0,63
Dagwisseling
$0,61 - $0,69
Jaarwisseling
$0,46 - $7,79
Markkapitalisasie
23,34 m USD
Gemiddelde volume
413,53 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Inkomste | — | — |
Bedryfskoste | 682,00 k | -75,92% |
Netto inkomste | -17,23 m | -50,77% |
Netto winsgrens | — | — |
Wins per aandeel | — | — |
EBITDA | — | — |
Effektiewe belastingkoers | — | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 4,00 k | -99,66% |
Totale bates | 1,85 m | -14,35% |
Totale aanspreeklikheid | 94,59 m | 48,22% |
Totale ekwiteit | -92,74 m | — |
Uitstaande aandele | 34,87 m | — |
Prys om te bespreek | -0,24 | — |
Opbrengs op bates | -71,09% | — |
Opbrengs op kapitaal | 2,48% | — |
Kontantvloei
Netto kontantverandering
| (USD) | Jun. 2024info | J/J-verandering |
|---|---|---|
Netto inkomste | -17,23 m | -50,77% |
Kontant van bedrywe | -290,00 k | 93,94% |
Kontant van beleggings | — | — |
Kontant van finansiering | — | — |
Netto kontantverandering | -290,00 k | -115,63% |
Beskikbare kontantvloei | -1,46 m | -70,74% |
Meer oor
Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources. Wikipedia
Gestig
2019
Webwerf
Werknemers
7
